Dexcom (Nasdaq:DXCM) announced today in an SEC filing that former CEO Kevin Sayer has returned from his leave of absence.
(NYSE:SENS) posted mixed fourth-quarter results compared to Wall Street forecasts alongside a major pipeline announcement.
Dexcom (Nasdaq:DXCM) announced that it appointed Rick Osterloh to its board of directors, effective Feb. 26, 2026.
Trinity Biotech (Nasdaq:TRIB) announced today that it entered into a $25 million Standby Equity Purchase Agreement (SEPA).
In an amendment to an SEC filing, Medtronic's Diabetes unit, MiniMed, today priced its planned initial public offering (IPO).
Tandem Diabetes Care (Nasdaq:TNDM) today announced the pricing of a $265 million offering of convertible senior notes.
Ascensia Diabetes Care, a PHC Holdings subsidiary, today announced the appointment of Peter Bodlund as president and CEO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results